Drug intolerance due to nonspecific adverse effects related to psychiatric morbidity in hypertensive patients

Archives of Internal Medicine

Volumn 163, Issue 5, 2003, Pages 592-600

  Davies, Simon J C ^a   Jackson, Peter R ^b   Ramsay, Lawrence E ^b   Ghahramani, Parviz ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHYLDOPA; VASODILATOR AGENT;

ADULT; AGED; ANXIETY; ARTICLE; CONTROLLED STUDY; COUGHING; DEPRESSION; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DRUG HYPERSENSITIVITY; DRUG SPECIFICITY; DYSPNEA; EDEMA; FATIGUE; FEMALE; FLUSHING; GASTROINTESTINAL SYMPTOM; GOUT; GYNECOMASTIA; HEART PALPITATION; HUMAN; HYPERTENSION; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PANIC; PRIORITY JOURNAL; PRURITUS; PSYCHIATRY; QUESTIONNAIRE; RASH; RATING SCALE; SLEEP DISORDER; SORE THROAT; URINARY FREQUENCY; WHEEZING;

AGE DISTRIBUTION; ANTIHYPERTENSIVE AGENTS; ANXIETY DISORDERS; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYPERTENSION; MALE; PANIC DISORDER; QUESTIONNAIRES; SEX DISTRIBUTION;

EID: 0037429642     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.5.592     Document Type: Article

References (39)

1. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke and coronary heart disease, II: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827-838.
2. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension. 1995;26:60-69.
3. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
4. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
5. Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens. 1998;16:747-752.
6. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ. 1995;311:293-295.
7. Bloom S. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther. 1998;20:671-681.
8. Lip GYH, Beevers DG. A survey of the current practice of treating hypertension in primary care: The Rational Evaluation and Choice in Hypertension (REACH) study. J Drug Dev Clin Pract. 1996;8:161-169.
9. Patriarca G, Schiavino D, Nucera E, Colamonico P, Montesarchio G, Saraceni C. Multiple drug intolerance: allergological and psychological findings. J Investig Allergol Clin Immunol. 1991;1:138-144.
10. Gifford RW Jr, Tarazi RC. Resistant hypertension: diagnosis and management. Ann Intern Med. 1978;88:661-665.
11. Yakovlevitch M, Black HR. Resistant hypertension in a tertiary care clinic. Arch Intern Med. 1991;151:1786-1792.
12. Davies SJC, Ghahramani P, Jackson PR, et al. Association of panic disorder and panic attacks with hypertension. Am J Med. 1999;107:310-316.
13. Bell CC, Hildreth CJ, Jenkins EJ, Carter C. The relationship of isolated sleep paralysis and panic disorder to hypertension. J Natl Med Assoc. 1988;80:289-294.
14. Kaplan NM. Anxiety-induced hyperventilation: a common cause of symptoms in patients with hypertension. Arch Intern Med. 1997;157:945-948.
15. Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiological Follow-up Study. Arch Fam Med. 1997;6:43-49.
16. Wells KB, Golding JM, Burnam MA. Chronic medical conditions in a sample of the general population with anxiety, affective, and substance use disorders. Am J Psychiatry. 1989;146:1440-1446.
17. Markovitz JH, Matthews KA, Wing RR, Kuller LH, Meilahn EN. Psychological, biological and health behavior predictors of blood pressure changes in middleaged women. J Hypertens. 1991;9:399-406.
18. Rabkin JG, Charles E, Kass F. Hypertension and DSM-III depression in psychiatric outpatients. Am J Psychiatry. 1983;140:1072-1074.
19. Davies SJC, Ghahramani P, Jackson PR, Hippisley-Cox J, Yeo WW, Ramsay LE. Panic disorder, anxiety and depression in resistant hypertension: a case-control study. J Hypertens. 1997;15:1077-1082.
20. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-363.
21. Spielberger CD, Gorsuch PL, Lushene R, Vagg PR, Jacobs GA. State-Trait Inventory for Adults. Palo Alto, Calif: Mind Garden; 1983.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
23. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID), : history, rationale, and description. Arch Gen Psychiatry. 1992;49:624-629.
24. Degoulet P, Menard J, Vu H-A, et al. Factors predictive of attendance at clinic and blood pressure control in hypertensive patients. BMJ. 1983;287:88-93.
25. Reidenberg MM, Lowenthal DT. Adverse nondrug reactions. N Engl J Med. 1968; 279:678-679.
26. Davies SJC, Ghahramani P, Jackson PR, Yeo WW, Ramsay LE. Panic attacks and hypertension: a relation with ischaemic heart disease [abstract]. J Hypertens. 1998;16(suppl 2):S213.
27. Caldecott-Hazard S, Morgan DG, DeLeon-Jones F, Overstreet DH, Janowsky D. Clinical and biochemical aspects of depressive disorders, II: transmitter/receptor theories. Synapse. 1991;9:251-256.
28. Gorman JM, Liebowitz MR, Fyer AJ, Stein J. A neuroanatomical hypothesis for panic disorder. Am J Psychiatry. 1989;146:148-161.
29. Neaton JD, Guimm RH, Prineas RJ, et al, for the Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study: final results. JAMA. 1993;270:713-724.
30. Materson BJ, Reda DJ, Cushman WC, et al, for the Department of Veterans Affairs Cooperative Study Group on Anthihypertensive Agents. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914-921.
31. Curb JD, Schneider K, Taylor JO, Maxwell M, Shulman N. Antihypertensive drug side-effects in the Hypertension Detection and Follow-up Program. Hypertension. 1988;11(3, pt 2):1151-1155.
32. Maronde RF, Chan LS, Larsen FJ, Strandberg LR, Laventurier MF, Sullivan SR. Underutilization of antihypertensive drugs and associated hospitalization. Med Care. 1989;27:1159-1166.
33. Psaty BM, Koepsell TD, Wagner EH, LoGerfo JP, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping the use of β-blockers. JAMA. 1990;263:1653-1657.
34. Davies SJC, Ghahramani P, Jackson PR, Hippisley-Cox J, Yeo WW, Ramsay LE. Panic attacks and panic disorder in hypertension, an important association often overlooked [abstract]. Am J Hypertens. 1998;11(4, suppl 2):21A.
35. Fleet RP, Dupuis G, Marchand A, Burelle D, Arsenault A, Beitman BD. Panic disorder in emergency department chest pain patients: prevalence, comorbidity, suicidal ideation, and physician recognition. Am J Med. 1996;101:371-380.
36. Gill D, Hatcher S. Antidepressants for depression in people with physical illness [Cochrane Review]. Oxford, England: Cochrane Library, Update Software Ltd; 2000:issue 4.
37. Ballenger JC. Current treatments of the anxiety disorders in adults. Biol Psychiatry. 1999;46:1579-1594.
38. American Psychiatric Association. Practice guidelines for the treatment of patients with panic disorder. Am J Psychiatry. 1998;155(5, suppl):1-34.
39. Clark DM, Salkovskis PM, Hackmann A, Middleton H, Anastasiades P, Gelder M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry. 1994;164:759-769.